Ticagrelor
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
42385-993 -
Package NDC
42385-993-01 -
Package NDC
42385-993-05 -
Package NDC
42385-993-11 -
Package NDC
42385-993-30 -
Package NDC
42385-993-60 -
Package NDC
42385-993-68 -
Package NDC
42385-993-72 -
Application number
ANDA218869 -
SPL ID
555d4e44-9bb2-474e-9bea-c549e3261dbb -
SPL set ID
555d4e44-9bb2-474e-9bea-c549e3261dbb -
UNII
GLH0314RVC -
RxCUI
1116635 -
RxCUI
1666332
What the source publishes
- Labeler
- Laurus Labs Limited
- Active ingredients
- Ticagrelor
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Ticagrelor",
"splId": "555d4e44-9bb2-474e-9bea-c549e3261dbb",
"labels": [
{
"setId": "555d4e44-9bb2-474e-9bea-c549e3261dbb",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=555d4e44-9bb2-474e-9bea-c549e3261dbb",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=555d4e44-9bb2-474e-9bea-c549e3261dbb"
}
],
"routes": [
"ORAL"
],
"labeler": "Laurus Labs Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (42385-993-01)",
"package_ndc": "42385-993-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20260820"
},
{
"sample": false,
"description": "500 TABLET in 1 BOTTLE (42385-993-05)",
"package_ndc": "42385-993-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20260820"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (42385-993-11)",
"package_ndc": "42385-993-11",
"identifierStatus": "well-formed",
"marketing_start_date": "20260820"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (42385-993-30)",
"package_ndc": "42385-993-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20260820"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (42385-993-60)",
"package_ndc": "42385-993-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20260820"
},
{
"sample": false,
"description": "10 BLISTER PACK in 1 CARTON (42385-993-68) / 10 TABLET in 1 BLISTER PACK (42385-993-10)",
"package_ndc": "42385-993-68",
"identifierStatus": "well-formed",
"marketing_start_date": "20260820"
},
{
"sample": false,
"description": "10 BLISTER PACK in 1 CARTON (42385-993-72) / 10 TABLET in 1 BLISTER PACK (42385-993-17)",
"package_ndc": "42385-993-72",
"identifierStatus": "well-formed",
"marketing_start_date": "20260820"
}
],
"productId": "42385-993_555d4e44-9bb2-474e-9bea-c549e3261dbb",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "42385-993",
"deaSchedule": null,
"genericName": "Ticagrelor",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TICAGRELOR",
"strength": "60 mg/1"
}
],
"applicationNumber": "ANDA218869",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260820",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000182142",
"N0000008832",
"N0000182143",
"N0000182141",
"N0000185503"
],
"upc": [
"0342385994308",
"0342385993301"
],
"unii": [
"GLH0314RVC"
],
"rxcui": [
"1116635",
"1666332"
],
"spl_set_id": [
"555d4e44-9bb2-474e-9bea-c549e3261dbb"
],
"pharm_class_pe": [
"Decreased Platelet Aggregation [PE]"
],
"pharm_class_epc": [
"P2Y12 Platelet Inhibitor [EPC]"
],
"pharm_class_moa": [
"P2Y12 Receptor Antagonists [MoA]",
"Cytochrome P450 3A4 Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]"
],
"manufacturer_name": [
"Laurus Labs Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:42385-993_555d4e44-9bb2-474e-9bea-c549e3261dbb"